Publication | Closed Access

Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling

InflammationFibrosisGanoderma Lucidum PolysaccharideHepatologyHsc ActivationLiver PhysiologyImmunologyPathologyCell DeathChronic InflammationHepatology InflammationHepatotoxicityLiver DiseaseCell CycleHepatology FibrosisMedicineCell BiologyCell Signaling